These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9350956)

  • 1. Relationship between neurological 'soft signs' and syndromes of schizophrenia.
    Malla AK; Norman RM; Aguilar O; Cortese L
    Acta Psychiatr Scand; 1997 Oct; 96(4):274-80. PubMed ID: 9350956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia.
    Prikryl R; Ceskova E; Kasparek T; Kucerova H
    J Psychiatr Res; 2006 Mar; 40(2):141-6. PubMed ID: 15907940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological soft signs in schizophrenic patients and their nonpsychotic siblings.
    Yazici AH; Demir B; Yazici KM; Göğüş A
    Schizophr Res; 2002 Dec; 58(2-3):241-6. PubMed ID: 12409164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspects of dysphoria and symptoms of schizophrenia.
    Norman RM; Malla AK; Cortese L; Diaz F
    Psychol Med; 1998 Nov; 28(6):1433-41. PubMed ID: 9854284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-Month stability of neurological soft signs in stabilized patients with schizophrenia.
    Fountoulakis KN; Panagiotidis P; Kimiskidis V; Nimatoudis I
    Nord J Psychiatry; 2019 Oct; 73(7):451-461. PubMed ID: 31393751
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables.
    de Bartolomeis A; Prinzivalli E; Callovini G; D'Ambrosio L; Altavilla B; Avagliano C; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():356-366. PubMed ID: 28887181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological soft signs in schizophrenic patients with obsessive-compulsive disorder.
    Sevincok L; Akoglu A; Topaloglu B; Arslantas H
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):274-9. PubMed ID: 15149293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological soft signs in schizophrenia: assessment and correlates.
    Mohr F; Hubmann W; Cohen R; Bender W; Haslacher C; Hönicke S; Schlenker R; Wahlheim C; Werther P
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(5):240-8. PubMed ID: 8863002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
    Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
    Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the factor structure of psychopathology in schizophrenia to the timing of initial intervention with antipsychotics.
    Meagher D; Quinn J; Murphy P; Kinsella A; Mullaney J; Waddington JL
    Schizophr Res; 2001 May; 50(1-2):95-103. PubMed ID: 11378318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
    Emsley R; Chiliza B; Asmal L; Kilian S; Riaan Olivier M; Phahladira L; Ojagbemi A; Scheffler F; Carr J; Kidd M; Dazzan P
    Schizophr Res; 2017 Oct; 188():144-150. PubMed ID: 28130002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trajectory of neurological examination abnormalities in antipsychotic-naïve first-episode psychosis population: a 1 year follow-up study.
    Lizano P; Dhaliwal K; Lutz O; Mothi SS; Miewald J; Montrose D; Keshavan M
    Psychol Med; 2020 Sep; 50(12):2057-2065. PubMed ID: 31451118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological signs and the heterogeneity of schizophrenia.
    Arango C; Kirkpatrick B; Buchanan RW
    Am J Psychiatry; 2000 Apr; 157(4):560-5. PubMed ID: 10739414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
    Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.
    Gupta S; Andreasen NC; Arndt S; Flaum M; Schultz SK; Hubbard WC; Smith M
    Am J Psychiatry; 1995 Feb; 152(2):191-6. PubMed ID: 7840351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between movement planning and psychopathology profiles in schizophrenia.
    Malla AK; Norman RM; Aguilar O; Carnahan H; Cortese L
    Br J Psychiatry; 1995 Aug; 167(2):211-5. PubMed ID: 7582671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficit of executive functions in schizophrenia: relationship to neurological soft signs and psychopathology.
    Bersani G; Clemente R; Gherardelli S; Pancheri P
    Psychopathology; 2004; 37(3):118-23. PubMed ID: 15153743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological soft signs and positive treatment response to olanzapine in chronic schizophrenia.
    Sevincok L; Topaloglu B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):141-3. PubMed ID: 16023278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological soft signs and their relationship to cognitive and clinical efficacy of atypical antipsychotics in schizophrenia.
    Das M; Kumari V; Soni W; Ettinger U; Binneman B; Hughes C; Mehrotra R; Sharma T
    Schizophr Bull; 2004; 30(2):241-53. PubMed ID: 15279043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3-year prospective study of neurological soft signs in first-episode schizophrenia.
    Chen EY; Hui CL; Chan RC; Dunn EL; Miao MY; Yeung WS; Wong CK; Chan WF; Tang WN
    Schizophr Res; 2005 Jun; 75(1):45-54. PubMed ID: 15820323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.